Conclusin Los agonistas de GLP-1R tienen revolucion el manejo de la diabetes y la obesidad , pero su papel en la atencin perioperatoria sigue siendo complejo
Psychological factors also warrant consideration
As a result, previous studies have examined the eryptotic properties of bisphenol A (BPA) and its substitute bisphenol S (BPS) [422], brominated flame retardants (BFRs) [421], and organophosphate flame retardants (OPFRs) [428]
Additional Wegovy-specific risks that require monitoring include pancreatitis (presenting as severe abdominal pain), cholelithiasis (gallstones), and potential worsening of diabetic retinopathy in patients with diabetes
In addition, one episode of severe hypoglycemia requiring intravenous glucose was reported in a WEGOVY-treated patient versus none in placebo-treated patients
Less commonly, Ozempic has been linked to vision changes